The effect of integrated cardiac rehabilitation versus treatment as usual for atrial fibrillation patients treated with ablation: The randomised CopenHeartRFA trial protocol

BMJ Open

Volumn 3, Issue 2, 2013, Pages

  Risom, Signe Stelling ^a   Zwisler, Ann Dorth Olsen ^a,b   Rasmussen, Trine Bernholdt ^a,c   Sibilitz, Kirstine Lærum ^a   Svendsen, Jesper Hastrup ^a,d   Gluud, Christian ^e   Hansen, Jane Lindschou ^e   Winkel, Per ^e   Thygesen, Lau Caspar ^b   Perhonen, Merja ^f   Hansen, Jim ^c   Dunbar, Sandra B ^g   Berg, Selina Kikkenborg ^a,c  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e Mental Health Center Glostrup   (Denmark)

^f CorusFit ^*  (Finland)

^g CLARK ATLANTA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONSULTATION; CONTROLLED STUDY; EXERCISE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART REHABILITATION; HUMAN; INTERMETHOD COMPARISON; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36;

EID: 84874959102     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-002377     Document Type: Article

References (95)

1. Stewart S, Hart CL, Hole DJ, et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart 2001;86:516-21. (Pubitemid 32999861)
2. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5. (Pubitemid 32424106)
3. Ruigomez A, Johansson S, Wallander MA, et al. Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK. BMC Cardiovasc Disord 2005;5:20.
4. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace 2010;12:1360-420.
5. Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, et al. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atral fibrillation (Review) 2009;The Cochrane Libraly(1).
6. Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 2007;9:1006-23. (Pubitemid 351773289)
7. Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002;113:359-64. (Pubitemid 35223606)
8. Camm J. Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits. Int J Cardiol 2011;155:362-71.
9. Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006;27:949-53.
10. Naccarelli GV, Varker H, Lin J, et al. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 2009;104:1534-9.
11. Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110:1042-6. (Pubitemid 39319000)
12. Ericson L, Bergfeldt L, Bjorholt I. Atrial fibrillation: the cost of illness in Sweden. Eur J Health Econ 2011;12:479-87.
13. Wolowacz SE, Samuel M, Brennan VK, et al. The cost of illness of atrial fibrillation: a systematic review of the recent literature. Europace 2011;13:1375-85.
14. Brenyo AJ, Aktas MK. Non-pharmacologic management of atrial fibrillation. Am J Cardiol 2011;108:317-25.
15. Calkins H, Reynolds MR, Spector P, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol 2009;2:349-61.
16. Atwood JE, Myers JN, Tang XC, et al. Exercise capacity in atrial fibrillation: a substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T). Am Heart J 2007;153:566-72. (Pubitemid 46440682)
17. Hansson A, Madsen-Hardig B, Olsson SB. Arrhythmia-provoking factors and symptoms at the onset of paroxysmal atrial fibrillation: a study based on interviews with 100 patients seeking hospital assistance. BMC Cardiovasc Disord 2004;4:13.
18. Hegbom F, Sire S, Heldal M, et al. Short-term exercise training in patients with chronic atrial fibrillation: effects on exercise capacity, AV conduction, and quality of life. J Cardiopulm Rehabil 2006;26:24-9. (Pubitemid 44474311)
19. Hegbom F, Stavem K, Sire S, et al. Effects of short-term exercise training on symptoms and quality of life in patients with chronic atrial fibrillation. Int J Cardiol 2007;116:86-92. (Pubitemid 46227610)
20. Osbak PS, Mourier M, Kjaer A, et al. A randomized study of the effects of exercise training on patients with atrial fibrillation. Am Heart J 2011;162:1080-7.
21. Dorian P, Jung W, Newman D, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 2000;36:1303-9.
22. McCabe PJ, Schumacher K, Barnason SA. Living with atrial fibrillation: a qualitative study. J Cardiovasc Nurs 2011;26:336-44.
23. Piepoli MF, Corra U, Benzer W, et al. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 2010;17:1-17.
24. Piepoli MF, Corra U, Adamopoulos S, et al. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery. Eur J Prev Cardiol 2012 Jun 20 [Epub ahead of print].
25. Heran BS, Chen JM, Ebrahim S, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2011;(7):CD001800.
26. Davies EJ, Moxham T, Rees K, et al. Exercise based rehabilitation for heart failure. Cochrane Database Syst Rev 2010;(4):CD003331.
27. Shepherd CW, While AE. Cardiac rehabilitation and quality of life: a systematic review. Int J Nurs Stud 2012;49:755-71.
28. Sire S. Physical training and occupational rehabilitation after aortic valve replacement. Eur Heart J 1987;8:1215-20. (Pubitemid 17163055)
29. Kitzman DW, Brubaker PH, Morgan TM, et al. Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. Circ Heart Fail 2010;3:659-67.
30. Clark AM, Catto S, Bowman G, et al. Design matters in secondary prevention: individualization and supervised exercise improves the effectiveness of cardiac rehabilitation. Eur J Cardiovasc Prev Rehabil 2011;18:761-9.
31. Clark AM, Haykowsky M, Kryworuchko J, et al. A meta-analysis of randomized control trials of home-based secondary prevention programs for coronary artery disease. Eur J Cardiovasc Prev Rehabil 2010;17:261-70.
32. Whalley B, Rees K, Davies P, et al. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev 2011;(8): CD002902.
33. Berg SK. Comprehensive rehabilitation for patients with ICD: PhD dissertation. Aarhus: Faculty of Health Sciences, Aarhus University, 2011.
34. Rasmussen TB, Zwisler AD, Sibilitz KL, et al. A randomised clinical trial of comprehensive cardiac rehabilitation versus usual care for patients treated for infective endocarditis - the CopenHeartIE. BMJ Open 2012;2:e001929.
35. Creswell JW, Plano Clark VL. Designing and conducting mixed methods research. Thousand Oaks, CA: SAGE Publications, 2007.
36. O'Cathain A, Murphy E, Nicholl J. Three techniques for integrating data in mixed methods studies. BMJ 2010;341:c4587.
37. Carter RE, Lubinsky J, Domholdt E. Rehabilitation research: principles and applications. 4th edn. St. Louis, MO: Elsevier Saunders, 2011.
38. Law MC, MacDermid J. Evidence-based rehabilitation: a guide to practice. 2nd edn. Thorofare, NJ: Slack, 2008.
39. Clark N, Boyd NR, Goodman RM, et al. Evaluation of health promotion, health education, and disease prevention programs. 3rd edn. Boston: McGraw-Hill, 2004.
40. Hammell KW, Carpenter C. Qualitative research in evidence-based rehabilitation. Edinburgh: Churchill Livingstone, 2004.
41. Lewin S, Glenton C, Oxman AD. Use of qualitative methods alongside randomised controlled trials of complex healthcare interventions: methodological study. BMJ 2009;339:b3496.
42. Neubeck L, Freedman SB, Clark AM, et al. Participating in cardiac rehabilitation: a systematic review and meta-synthesis of qualitative data. Eur J Prev Cardiol 2012;19:494-503.
43. Chan A, Tetzlaff J, Altman D, et al. The SPIRIT initiative: defining Standard Protocol Items for Randomized Trials [conference abstract]. German J Evid Quality Health Care (Suppl) 2008;102:S27.
44. Boutron I, Moher D, Altman DG, et al. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008;148:295-309. (Pubitemid 351665487)
45. Mertens DJ, Kavanagh T. Exercise training for patients with chronic atrial fibrillation. J Cardiopulm Rehabil 1996;16:193-6. (Pubitemid 26162598)
46. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-17.
47. Rikli RE, Jones CJ. Senior fitness test manual. Champaign, IL: Human Kinetics, 2001.
48. Ekholm O, Hesse U, Davidsen M, et al. The study design and characteristics of the Danish national health interview surveys. Scand J Public Health 2009;37:758-65.
49. Ware JE, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation guide. Boston MA: The Health Institute, New England Medical Center, 2005.
50. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70. (Pubitemid 13098606)
51. Ferrans CE, Powers MJ. Quality of life index: development and psychometric properties. Adv Nurs Sci 1985;8:15-24.
52. Bowman G, Watson R, Trotman-Beasty A. Primary emotions in patients after myocardial infarction. J Adv Nurs 2006;53:636-45. (Pubitemid 43383430)
53. Bøgelund M, Mønsted C. Hjertepatienters brug og oplevelse af rehabilitering 2010. Copenhagen: Hjerteforeningen, 2010.
54. Oldridge N, Saner H, McGee HM, et al. The Euro Cardio-QoL Project. An international study to develop a core heart disease health-related quality of life questionnaire, the HeartQoL. Eur J Cardiovasc Prev Rehabil 2005;12:87-94. (Pubitemid 40571522)
55. Drummond MF. Methods for the economic evaluation of health care programmes. 3rd edn. Oxford: Oxford University Press, 2005.
56. Hallal PC, Victora CG. Reliability and validity of the International Physical Activity Questionnaire (IPAQ). Med Sci Sports Exerc 2004;36:556. (Pubitemid 38298710)
57. Schwartz JE, Jandorf L, Krupp LB. The measurement of fatigue: a new instrument. J Psychosom Res 1993;37:753-62. (Pubitemid 23285135)
58. Buysse DJ, Reynolds CF 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213. (Pubitemid 19144991)
59. Spertus J, Dorian P, Bubien R, et al. Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol 2011;4:15-25.
60. Berg SK, Svendsen JH, Zwisler AD, et al. COPE-ICD: a randomised clinical trial studying the effects and meaning of a comprehensive rehabilitation programme for ICD recipients -design, intervention and population. BMC Cardiovasc Disord 2011;11:33.
61. Zwisler A, Madsen M, Konstantin Nissen N. Hjerterehabilitering: en medicinsk teknologivurdering: evidens fra litteraturen og DANREHAB- forsøget. http://www.si-folkesundhed.dk/upload/ hjerterehabilitering-001. pdf Version: 1,0 ed. Kbh: Sundhedsstyrelsen, 2006 (accessed 12 Aug 2012).
62. Anbefalinger for fysisk aktivitet. http://www.sst.dk/Sundhed%20og% 20forebyggelse/Fysisk%20aktivitet/Anbefalinger%20til%20voksne. aspx (accessed 13 Sep 2011).
63. Oerkild B, Frederiksen M, Hansen JF, et al. Home-based cardiac rehabilitation is as effective as centre-based cardiac rehabilitation among elderly with coronary heart disease: results from a randomised clinical trial. Age Ageing 2011;40:78-85.
64. Fitchet A, Doherty PJ, Bundy C, et al. Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial. Heart 2003;89:155-60. (Pubitemid 36115096)
65. Lampman RM, Knight BP. Prescribing exercise training for patients with defibrillators. Am J Phys Med Rehabil 2000;79:292-7. (Pubitemid 30321524)
66. Parse RR. The human becoming school of thought: a perspective for nurses and other health professionals. Thousand Oaks, CA: Sage, 1998.
67. Berg SK, Pedersen BD, Svendsen JH, et al. COPE-ICD: patient experience of participation in an ICD specific rehabilitation programme. Eur J Cardiovasc Nurs 2012;11:207-15.
68. Mezzani A, Agostoni P, Cohen-Solal A, et al. Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac patients: a report from the Exercise Physiology Section of the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 2009;16:249-67.
69. Gibbons L, Blair SN, Kohl HW, et al. The safety of maximal exercise testing. Circulation 1989;80:846-52. (Pubitemid 19261631)
70. Bjørner JB, Trab Damsgaard M, Watt T, et al. Dansk manual til SF-36: et spørgeskema om helbredsstatus. (S.l.): Lif, 1997.
71. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
72. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
73. Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-8. (Pubitemid 29299976)
74. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011;39(7 Suppl):30-3.
75. Andersen JS, Olivarius Nde F, Krasnik A. The Danish National Health Service Register. Scand J Public Health 2011;39(7 Suppl):34-7.
76. Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011;39(7 Suppl):38-41.
77. Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health 2011;39(7 Suppl):26-9.
78. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377-81. (Pubitemid 13215050)
79. DeSouza CM, Legedza AT, Sankoh AJ. An overview of practical approaches for handling missing data in clinical trials. J Biopharm Stat 2009;19:1055-73.
80. Dmitrienko A, Wiens BL, Tamhane AC, et al. Tree-structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives. Stat Med 2007;26:2465-78. (Pubitemid 46784205)
81. McHorney CA, Ware JE, Rogers W, et al. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts: results from the Medical Outcomes Study. Med Care 1992;30(Suppl):253-65.
82. Schweikert B, Hahmann H, Leidl R. Validation of the EuroQol questionnaire in cardiac rehabilitation. Heart 2006;92:62-7. (Pubitemid 43021857)
83. Polit DF, Beck CT. Essentials of nursing research: methods, appraisal, and utilization. 6 edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2006.
84. Ricoeur P. Interpretation theory: discourse and the surplus of meaning. 5th print edn. FortWorth, TX: Texas Christian University Press, 1976.
85. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990;16:199-208.
86. Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72. (Pubitemid 26191458)
87. Wittrup-Jensen KU, Lauridsen J, Gudex C, et al. Generation of a Danish TTO value set for EQ-5D health states. Scand J Public Health 2009;37:459-66.
88. Fox-Rushby JA, Cairns J. Economic evaluation. Maidenhead: Open University Press, 2005.
89. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10:779-87. (Pubitemid 34041389)
90. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004;116:682-92. (Pubitemid 38581114)
91. Rees K, Taylor RS, Singh S, et al. Exercise based rehabilitation for heart failure. Cochrane Database Syst Rev 2004;(3):CD003331.
92. Wood L, Egger M, Gluud LL, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336:601-5. (Pubitemid 351439518)
93. Gluud L. Bias in clinical intervention research. Am J Epidemiol 2006;163:493-501.
94. Savovic J, Jones H, Altman D, et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. Health Technol Assess 2012;16: 1-82.
95. Rowland T, Unnithan V, Barker P, et al. Time-of-day effect on cardiac responses to progressive exercise. Chronobiol Int 2011;28:611-16.